NCT07097142 2026-04-08
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
NRG Oncology
Phase 3 Recruiting
Clinical Trials
16 trialsNCT06704191 2026-03-30
In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial
Mayo Clinic
Phase 1/2 Recruiting
NCT03348969 2026-03-03
NICSA
Aarhus University Hospital
Phase 4 Completed
NCT07189793 2025-09-24
OHAI-NMIBC-01
First Affiliated Hospital of Wenzhou Medical University
Phase 2 Not yet recruiting
NCT05024734 2025-03-11
GAIN INST
Hospital Centre Biel/Bienne
Phase 2 Recruiting
NCT06227065 2024-01-26
POLO
University of Bern
Phase 2 Not yet recruiting
NCT02948543 2023-06-18
BCG+MM
University of Sydney
Phase 3 Unknown
NCT02695771 2023-04-21
BIC
Corewell Health West
Phase 3 Completed
NCT03617913 2023-01-06
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer
Mayo Clinic
Phase 2 Completed
NCT03844256 2022-08-12
CRIMI
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 1/2 Recruiting
NCT02070120 2020-03-19
CALIBER
Institute of Cancer Research, United Kingdom
Phase 2 Unknown
NCT03790384 2018-12-31
MITOBCG
Azienda Ospedaliera "Sant'Andrea"
Phase 4 Unknown
NCT03694535 2018-10-03
Intravesical Thermochemotherapy With Mitomycin-c
TC Erciyes University
Phase NA Completed
NCT02311101 2015-12-03
Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer
The University of Texas Health Science Center at San Antonio
Phase 1 Completed
NCT00974818 2015-11-20
Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase 3 Terminated
NCT01442519 2011-09-28
BCG/EMDA-MMC
University of Rome Tor Vergata
Phase 3 Completed